Controlled release formulations

Details Controlled release formulations Controlled release formulations

A - Human Necessities

61

K

A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 31/401 (2006.01)

Patent

CA 2653625

The invention relates to a controlled release formulation for an oral cytokine inhibitor of interleukin-1 beta converting enzyme.

L'invention concerne une formulation à libération contrôlée destinée à l'administration orale d'un inhibiteur de cytokine de l'enzyme de conversion de l'interleukine-1 bêta.

Affiliated with

Also associated with

Rating

Controlled release formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1605593